EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1750-1172

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa ; volume:14 ; number:1 ; day:3 ; month:12 ; year:2019 ; pages:1-6 ; date:12.2019
Orphanet journal of rare diseases ; 14, Heft 1 (3.12.2019), 1-6, 12.2019

Creator: Diociaiuti, Andrea
Steinke, Holger
Nyström, Alexander
Schwieger-Briel, Agnes
Meiß, Frank
Pfannenberg, Christina
Bruckner-Tuderman, Leena
Ruf, Juri
Vito, Rita De
Hachem, May El
Kiritsi, Dimitra

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13023-019-1262-7

URN: urn:nbn:de:101:1-2020032620460958742126

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Diociaiuti, Andrea
Steinke, Holger
Nyström, Alexander
Schwieger-Briel, Agnes
Meiß, Frank
Pfannenberg, Christina
Bruckner-Tuderman, Leena
Ruf, Juri
Vito, Rita De
Hachem, May El
Kiritsi, Dimitra
SpringerLink (Online service)

Other Objects (12)

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

STAT3 targeting in dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa - from biochemistry to interventions

Hochschulschrift

Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa

Hochschulschrift

Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

STAT3 targeting in dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa - from biochemistry to interventions

Hochschulschrift

Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa

Hochschulschrift

Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

STAT3 targeting in dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa - from biochemistry to interventions

Hochschulschrift

Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa

Hochschulschrift

Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

STAT3 targeting in dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa - from biochemistry to interventions

Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa

Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

STAT3 targeting in dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa - from biochemistry to interventions

Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa

Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

STAT3 targeting in dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa - from biochemistry to interventions

Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa

Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

Type VII collagen deficiency in the oncogenesis of cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

Related objects

Reset password